Phase II Multicenter Single-arm Study of BKM120 Plus Capecitabine for Breast Cancer Patients With Brain Metastases
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Buparlisib (Primary) ; Capecitabine
- Indications Breast cancer
- Focus Therapeutic Use
- 29 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2017 Biomarkers information updated
- 18 May 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2017.